Litcius/Paper detail

Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial

Subodh Verma, Lawrence A. Leiter, Hwee Teoh, G.B. John Mancini, Adrian Quan, Randi Elituv, Meena Verma, Elizabeth Misner, Michael Szarek, Kevin E. Thorpe, Tarit Saha, Richard Whitlock, Bobby Yanagawa, Béla Merkely, Peter Jüni, Michael Koren, Stephen J. Nicholls, Deepak L. Bhatt, C. David Mazer

2025The Lancet20 citationsDOI

Topics & Concepts

MedicineEvolocumabSaphenous vein graftPlaceboArterySurgeryVeinCardiologyCoronary artery bypass surgeryInternal medicineApolipoprotein A1PathologyAlternative medicineCholesterolApolipoprotein BCardiac and Coronary Surgery TechniquesAtherosclerosis and Cardiovascular DiseasesCoronary Interventions and Diagnostics
Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial | Litcius